Inventor
HSU YEN-MING
US30 patents
⚠️ This page may combine multiple inventors who share the name “HSU YEN-MING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOGEN IDEC INC
7 patentsUS8821883B2Sep 2, 2014
Method of treating B cell cancers by administering truncated BAFF receptors
BIOGEN IDEC INC14 citations92
US7700317B2Apr 20, 2010
Truncated baff receptors
BIOGEN IDEC INC15 citations92
US8022182B2Sep 20, 2011
Truncated BAFF receptors
BIOGEN IDEC INC2 citations62
US9097726B2Aug 4, 2015
Methods of evaluating BAFF
BIOGEN IDEC INC1 citations61
US8685657B2Apr 1, 2014
Methods of evaluating BAFF
BIOGEN IDEC INC1 citations61
US7087390B2Aug 8, 2006
CAIP-like gene family
BIOGEN IDEC INC0 citations52
US9297810B2Mar 29, 2016
CD40L-binding agent based platelet aggregation assays
BIOGEN IDEC INC0 citations51
BIOGEN INC
6 patentsUS7173046B2Feb 6, 2007
CD40:CD154 binding interrupter compounds and use thereof to treat immunological complications
BIOGEN INC22 citations89
US5837844ANov 17, 1998
CAIP-like gene family
BIOGEN INC5 citations62
US5656438AAug 12, 1997
CAIP-like gene family
BIOGEN INC5 citations62
US5641748AJun 24, 1997
Caip-like gene family
BIOGEN INC5 citations62
US6423824B1Jul 23, 2002
CAIP-like gene family
BIOGEN INC0 citations52
US6171800B1Jan 9, 2001
Method of making and binding CAIP polypeptides
BIOGEN INC1 citations52
HSU YEN-MING
4 patentsUS8617545B2Dec 31, 2013
Methods for use with BAFF antagonists
HSU YEN-MING8 citations79
US8415111B2Apr 9, 2013
Methods of evaluating BAFF
HSU YEN-MING1 citations60
US8202698B2Jun 19, 2012
Methods of evaluating BAFF
HSU YEN-MING3 citations60
US8409810B2Apr 2, 2013
Platelet aggregation assays using a CD40L-binding agent
HSU YEN-MING0 citations50
Ab biosciences inc
3 patentsUS11801286B2Oct 31, 2023
Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use
Ab biosciences inc0 citations57
US11304994B2Apr 19, 2022
Recombinant intravenous immunoglobulin (rIVIG) compositions and methods for their production and use
Ab biosciences inc0 citations57
US9494597B2Nov 15, 2016
Human control antibodies and uses therefor
Ab biosciences inc0 citations47
UCB PHARMA SA
2 patentsUS8784823B2Jul 22, 2014
Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
UCB PHARMA SA38 citations96
US9321840B2Apr 26, 2016
Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof
UCB PHARMA SA2 citations61